Brief: Anika Therapeutics Q1 Revenue USD 26.168 Million
09/05/2025 12:06
May 09 (Reuters) - Anika Therapeutics Q1 net income USD -4.873 million. Q1 income from operations USD -4.284 million Q1 gross profit USD 14.681 million Q1 pretax profit USD -3.869 million
Recent news on Anika Therapeutics
See all newsAnika Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Anika Therapeutics Q2 revenue rises, lifts 2026 outlook
Anika Therapeutics Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Anika Therapeutics Enters Fifth Amendment To Credit Agreement - SEC Filing
Anika Therapeutics Q1 revenue rises 13%